Monday, April 10, 2017
Aerie Pharmaceuticals Names New VPs
Irvine-based Aerie Pharmaceuticals, a pharmaceuticals company developing treatments for glaucoma and other eye diseases, said it has named Gary Menichini as Vice President of Sales, Dale Seibt as Vice President of Market Access, and Gerry McKenzie as Vice President of Commercial Operations. The company also has appointed Michael McCleerey to the new position of Vice President of Portfolio Development. Menichi was previously at Genoptix, and also served at Alcon Laboratories; Seibt was previously at Alcon Laboratories; McKenzie was at Allergan.